Treatment of inflammatory bowel disease with genetically engineered bacteria
- PMID: 20600056
- DOI: 10.1053/j.gastro.2010.06.037
Treatment of inflammatory bowel disease with genetically engineered bacteria
Comment on
-
Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus.Gut. 2010 Apr;59(4):461-9. doi: 10.1136/gut.2008.176131. Epub 2009 Sep 7. Gut. 2010. PMID: 19736360
Publication types
LinkOut - more resources
Full Text Sources